Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Total Assets 2009–2025
Neurocrine Biosciences Inc. annual total assets history from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Neurocrine Biosciences Inc. total assets as of December 31, 2025: 4.63B, a 24.55% increase year-over-year.
- Neurocrine Biosciences Inc. total assets for 2025 were 4.63B, a 24.55% increase from 2024.
- Neurocrine Biosciences Inc. total assets for 2024 were 3.72B, a 14.37% increase from 2023.
- Neurocrine Biosciences Inc. total assets for 2023 were 3.25B, a 37.27% increase from 2022.
- Neurocrine Biosciences Inc. total assets for 2022 were 2.37B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Neurocrine Biosciences Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $4,632 |
| 2024 | $3,719 |
| 2023 | $3,251 |
| 2022 | $2,369 |
| 2021 | $2,073 |
| 2020 | $1,735 |
| 2019 | $1,306 |
| 2018 | $993 |
| 2017 | $818 |
| 2016 | $365 |
| 2015 | $475 |
| 2014 | $243 |
| 2013 | $155 |
| 2012 | $196 |
| 2011 | $138 |
Neurocrine Biosciences Inc. Total Assets — FAQ
Neurocrine Biosciences Inc. (NBIX) total assets over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's total assets history?
The chart and table above show Neurocrine Biosciences Inc.'s total assets by year and by quarter, including the growth rate.